US 10028944
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted A61KA61K31/194A61K31/4468
Quick answer
US patent 10028944 (Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases) held by ACADIA Pharmaceuticals Inc. expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ACADIA Pharmaceuticals Inc.
- Grant date
- Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/194, A61K31/4468, A61K45/06, A61K9/20